Recurrent Small Lymphocytic Lymphoma Clinical Trials in Chapel Hill, North Carolina

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia